Financial Daily from THE HINDU group of publications
Sunday, January 16, 2005

News
Features
Stocks
Port Info
Archives
Google

Subscription

Group Sites

CORPORATE RESULTS

PHARMACEUTICALS


Aurobindo Pharma gets nod for Metformin; Q3 net down at Rs 10.6 cr
AUROBINDO Pharma Ltd, the Hyderabad-based pharmaceutical company, has announced that the United States Food and Drug Administration (USFDA) has granted approval for its abbreviated new drug application for Metformin, indicated for the treatment ... More

Suven Q3 net profit drops
HYDERABAD: Suven Life Sciences Ltd, the Hyderabad-based pharma company, has suffered a fall in net profit for the third quarter of current fiscal ended December 2004 despite registering a growth in turnover. According to the unaudited ... More

AUTOMOBILE COMPONENTS


Bharat Forge PAT up 25%
MUMBAI: Auto components company Bharat Forge Ltd has reported a 25.5 per cent increase in profit after tax (PAT) at Rs 41.4 crore for the third quarter in 2004-05. The net profit increase was contributed by a 76 per cent rise in exports ... More


Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
Pick a Winner Stock Market Contest

Top Stories
BSNL, MTNL launch broadband service — Plan to rope in million subscribers by year-end


Forex reserves decline $2 b on revaluation of currencies

Indirect tax collections up 12.23% in April-Dec

`India must stop harping on US-Pak ties'

In Focus

BHEL Disinvestment
The Yuan Revaluation
Dabhol power regenerated
Tracking the rains
Sethusamudram Canal Project
India Inc's overseas acquisition
More

In Depth

Gender Justice
Simple Economics
Tax Talk
More

Looking back
Jan. 9-Jan. 15
MphasiS BFL Q3 net declines to Rs 27 cr

Infosys widens clientele, sees good growth in BPO biz

Hero Honda Q3 net up 8 pc


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line